Clarus Ventures, LLC 13F Holdings · last filed Q3 2018
Clarus Ventures, LLC reported 10 securities worth $425.48M in its SEC 13F filing for Q3 2018 (period ended 2018-09-30). Top holdings: TECX (36.11%), NSTG (16.91%), SIENQ (15.33%). Among its top 25 positions this quarter: 2 new, 1 added.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | TECX | AvroBio Inc. | $153.7M | 36.11% | 3.0M | Hold |
| 2 | NSTG | Nanostring Technologies Inc. | $72.0M | 16.91% | 4.0M | Added |
| 3 | SIENQ | Sientra Inc. | $65.2M | 15.33% | 2.7M | Hold |
| 4 | FTSV | Forty Seven Inc | $56.9M | 13.38% | 3.8M | Hold |
| 5 | GRTS | Gritstone Oncology Inc | $36.6M | 8.59% | 2.6M | New |
| 6 | ETTX | Entasis Therapeutics Holdings Inc | $17.7M | 4.15% | 1.6M | New |
| 7 | VERO | Restoration Robotics Inc. | $10.4M | 2.43% | 3.6M | Hold |
| 8 | VBIV | VBI Vaccines Inc. | $6.5M | 1.53% | 2.7M | Hold |
| 9 | EPIX | ESSA Pharma Inc. | $5.0M | 1.18% | 1.7M | Hold |
| 10 | ATXS | Catabasis Pharmaceuticals Inc. | $1.6M | 0.38% | 2.0M | Hold |
Source: SEC Form 13F filings · as of 2018-09-30
Every position in this 13F-HR, with its change from the prior quarter.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR